----------------------------------------------------------------------

Did you know? Our assessment and impact rating along with detailed
information such as exploit code availability, or if an updated patch
is released by the vendor, is not part of this mailing-list?
        
Click here to learn more about our commercial solutions:
http://secunia.com/advisories/business_solutions/
        
Click here to trial our solutions:
http://secunia.com/advisories/try_vi/

----------------------------------------------------------------------

TITLE:
Agavi URL-Handling Cross-Site Scripting Vulnerability

SECUNIA ADVISORY ID:
SA33982

VERIFY ADVISORY:
http://secunia.com/advisories/33982/

DESCRIPTION:
A vulnerability has been reported in Agavi, which can be exploited by
malicious people to conduct cross-site scripting attacks.

Input passed to the application via the URL is not properly sanitised
before being returned to the user. This can be exploited to execute
arbitrary HTML and script code in a user's browser session in the
context of an affected site.

This vulnerability is reported in the following versions:
- 0.11 up to and including 0.11.6-RC2
- 1.0 up to and including 1.0.0-beta7

SOLUTION:
Update to version 0.11.6.

This vulnerability is fixed in version 1.0.0 beta8.

PROVIDED AND/OR DISCOVERED BY:
The vendor credits Daniel Kubitza.

ORIGINAL ADVISORY:
http://trac.agavi.org/ticket/1019

----------------------------------------------------------------------

About:
This Advisory was delivered by Secunia as a free service to help
everybody keeping their systems up to date against the latest
vulnerabilities.

Subscribe:
http://secunia.com/advisories/secunia_security_advisories/

Definitions: (Criticality, Where etc.)
http://secunia.com/advisories/about_secunia_advisories/


Please Note:
Secunia recommends that you verify all advisories you receive by
clicking the link.
Secunia NEVER sends attached files with advisories.
Secunia does not advise people to install third party patches, only
use those supplied by the vendor.

----------------------------------------------------------------------